Oxford Finance Provides $150MM Loan Facility to Lexicon Pharmaceuticals
Lexicon Pharmaceuticals entered into a loan facility with Oxford Finance that provides up to $150 million in borrowing capacity designed primarily to support commercial preparations and the potential launch of sotagliflozin for heart failure.
March 21, 2022
Jeffrey L. Wade | Lexicon Pharmaceuticals | Oxford Finance
Ian Koplin